Health Screening Market to Receive Highest Growth of US$ 6,09,134 Million by 2029
A Qualitative Research Study accomplished by Data Bridge Market research’s database of 350 pages, titled as “Global Health Screening Market” with 100+ market data Tables, Pie Charts, Graphs & Figures spread through Pages and easy to understand detailed analysis.
The market for health screening is estimated to increase rapidly over the forecast period. According to a study conducted by the University of Utah GSLC, researchers were able to achieve telomerase activity inhibition in prostate and breast cancer cells cultivated in the lab, resulting in tumor cell death. As a result of these studies, telomere test kits in cellular health screening and other applications have increased, which is projected to boost the health screening market in the forecast years. Hence, an increase in the frequency of chronic diseases and an increase in the geriatric population has resulted in the high demand for health screening in the market.
Data Bridge Market Research analyses that the health screening market was valued at USD 2,11,225.2 million in 2021 and is expected to reach USD 6,09,134 million by 2029, registering a CAGR of 12.4% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-health-screening-market&Shri
Market Overview:
Health screening is an important tool for detecting a disease early on. Screening tests are frequently used in preventative medicine to determine whether a person displays early indicators of a condition’s risk factors. Cancer, diabetes, high cholesterol, high blood pressure, and osteoporosis are all diseases that can be discovered by screening.
Drivers
- Increasing prevalence of chronic diseases
The rising prevalence of chronic diseases such as diabetes, high blood pressure, cancer, high cholesterol, and osteoporosis will propel the market’s growth rate during the forecast period of 2022-2029.
- Rise in the number of geriatric population
The number of persons aged 60 and up has consistently increased over time as a result of rising life expectancy. The worldwide geriatric population will grow from 727 million in 2020 to 1.5 billion by 2050, according to the United Nations Database on World Population Ageing 2020. Geriatric people are the highest risk of suffering from chronic diseases, increasing the demand for the health screening market.
Furthermore, the rising awareness about early detection and treatment of disease will be a major factor influencing the growth of the health screening market. Along with this, increasing urbanization and rising level of disposable income are the driving factors accelerating the growth of the health screening market. Also, increasing expenditure on healthcare infrastructure and the continuously changing lifestyle of people are the major market drivers that will further escalate the growth of health screening market.
Recent Development
- In November 2021, Evoq Technologies LLC had announced the launch of first smartphone-based product for retinal health testing. The “SmartERG” Platform is designed to assess the retinal health of the eye in novel ways. With the force multipliers of simple patient-provider connection, cloud-based analytical services, and a great fit for artificial intelligence, the SmartERG Platform will offer a breakthrough delivery approach for ophthalmic patient care.
- In September 2021, Eurofins Scientific SE’s subsidiary Transplant Genomics had announced the launch of OmniGraf. It combines the Viracor TRAC donor-derived cell-free DNA assays with the TruGraf blood gene expression test. OmniGraf Kidney is the first diagnostic tool for renal transplant recipients that integrates cell-free DNA and gene expression data. When paired with TGI’s unique technology and machine learning, the test provides patients with the most accurate and timely assessment of kidney transplant rejection.
Some of the major players operating in the health screening market are:
- Quest Diagnostics Incorporated (US)
- GRAIL(US)
- Eurofins Scientific (Luxembourg)
- Exact Sciences Corporation (US)
- SYNLAB International GmbH (Germany)
- UNILABS (Switzerland)
- LabPLUS (US)
- BioReference Laboratories (US)
- Sonic Healthcare Limited (Australia)
- ACM Global Laboratories (NY)
- Cerba Healthcare (France)
- Quidel Corporation (US)
- Innova Medical Group (US)
- Amedes Holding GmbH (Germany)
- RadNet, Inc. (US)
- Natera, Inc. (US)
- Trinity Biotech (Ireland)
- Nuffield Health (UK)
- RepeatDx (Canada)
- NeoGenomics Laboratories (US)
- H.U Group Holdings, Inc. (Japan)
- ARUP Laboratories (US)
- Q2 Solutions (US)
- Genova Diagnostics (US)
To Gain More Insights into the Market Analysis, Browse Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-health-screening-market?Shri
Global Health Screening Market Scope
The health screening market is segmented on the basis of test type, package type, panel type, sample type, technology, condition, sample collection sites, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Test Type
- Cholesterol Tests
- Diabetes Test
- Cancer Screening
- General Check Up Test
- STDs
- Blood Pressure Test
- Others
On the basis of test type, the global health screening market is segmented into cholesterol tests, diabetes tests, cancer screening, general checkup test, STDs, blood pressure test, and others. In 2021, the cholesterol test segment is expected to dominate the market because of the rise in cardiac diseases and changing lifestyle patterns.
Package Type
- Basic Health Screening
- Senior Citizen Profile
- Women Health Check
- Men Health Check
- Heart Check
- Diabetes Check
- Others
On the basis of package type, the global health screening market is segmented into basic health screening, senior citizen profile, women health check, men health check, heart check, diabetes check, and others. In 2021, the basic health screening segment is expected to dominate the market because of increasing awareness among people for early diagnosis of disease and proper medication.
Panel Type
- Multi-Test Panels
- Single-Test Panels
On the basis of panel type, the global health screening market is segmented into multi-test panels and single-test panels. In 2021, the multi-test panels segment is expected to dominate the market as various laboratories, and diagnostic centers use multi-test panels to screen for multiple substances at once. Multi-test panels screen drugs for multiple substances at once rather than one substance per test. These tests are more comprehensive.
Sample Type
- Blood
- Urine
- Serum
- Saliva
- Others
On the basis of sample type, the global health screening market is segmented into blood, urine, serum, saliva, and others. In 2021, the blood segment is expected to dominate the market because blood tests can help identify how well the organs are working, such as the heart, kidneys, and liver, among others.
Technology
- Immunoassays
- Medical Imaging
- QPCR (Quantitative Polymerase Chain Reaction)
- Q-FISH (Quantitative Fluorescence, in Situ Hybridization)
- TRF (Terminal Restriction Fragment)
- STELA (Single Telomere Length Analysis)
- Others
On the basis of technology, the global health screening market is segmented into immunoassays, medical imaging, QPCR (Quantitative Polymerase Chain Reaction), Q-FISH (Quantitative Fluorescence, in situ hybridization), TRF (Terminal Restriction Fragment), STELA (Single Telomere Length Analysis), and others. In 2021, the immunoassays segment is expected to dominate the market because immunoassays contribute to various applications, including blood transfusions, gene therapies, implant operations, screening of infectious diseases, and others. The increasing number of surgeries, infectious diseases, and gene therapies are driving the growth of the immunoassays segment.
Condition
- Cardiovascular Disease
- Metabolic Disorders
- Cancer
- Inflammatory Conditions
- Musculoskeletal Disorders
- Neurological Conditions
- Hepatitis-C Complications
- Immunology-Related Conditions
- Others
On the basis of condition, the global health screening market is segmented into cardiovascular disease, metabolic disorders, cancer, inflammatory conditions, musculoskeletal disorders, neurological conditions, Hepatitis-C complications, immunology-related conditions, and others. In 2021, the cardiovascular disease segment is expected to dominate the market because of the high prevalence of cardiovascular diseases worldwide.
Sample Collection Sites
- Hospital
- Homes
- Diagnostic Laboratories
- Offices
- Others
On the basis of sample collection sites, the global health screening market is segmented into hospitals, homes, diagnostic laboratories, offices, and others. In 2021, the hospitals segment is expected to dominate the market as hospitals have all the facilities to diagnose and treat the disorders.
Distribution Channel
- Direct Tenders
- Retail Sales
- Others
This Market Intelligence Report Analyses Some of the Most Crucial Concerns:
- How will the major segments of this international market develop over the next few years?
- Who are the major players that will dominate the market in the future?
- When it comes to this industry, who are the top suppliers and producers?
- How have the most successful companies in the industry planned for future growth and expansion?
- In what sectors might we expect to see the greatest increase in demand over the coming years?
- How many distinct subsets of buyers make up this market?
- Which regional powerhouse do you foresee as becoming the largest player in the international market?
- Does a new coronavirus pandemic have any consequences?
- In what ways are established actors stymied by the entry of newcomers, and how may they be overcome?
Browse the complete table of contents at – https://www.databridgemarketresearch.com/toc/?dbmr=global-health-screening-market&Shri
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cellular-health-screening-market
https://www.databridgemarketresearch.com/reports/asia-pacific-health-screening-market
https://www.databridgemarketresearch.com/reports/north-america-health-screening-market
https://www.databridgemarketresearch.com/reports/middle-east-and-africa-health-screening-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com
